News

Here’s a microcap punting on bringing back Le Tan – and asset manager CVC wants in

November 30, 2018November 29, 2018 | Brian Robins

Mining

This minnow saw off challenges from Japan and China to get a mine off the ground

November 30, 2018November 30, 2018 | Brian Robins

Health & Biotech

Insider buying could be a signal to cheer at troubled Smiles Inclusive

November 29, 2018November 29, 2018 | Brian Robins

Health & Biotech

SomnoMed boss apologises for upsetting dentists, shares surge

November 28, 2018November 28, 2018 | Brian Robins

Tech

What’s next for data encryptor Senetas as it waits for distributor buy-out

August 7, 2018August 7, 2018 | Brian Robins

Tech

What’s next for high-tech removalist Updater as positive cashflow beckons

August 6, 2018August 6, 2018 | Brian Robins

Tech

How tiddler telco United Networks is slowly righting the ship

August 6, 2018August 6, 2018 | Brian Robins

Energy

How the political storm over energy is impacting ASX renewable stocks

August 3, 2018February 10, 2019 | Brian Robins

Health & Biotech

A year after cold shower Acrux rebuild gets underway with first generic drug

August 3, 2018August 3, 2018 | Brian Robins

Experts

Why one of the market’s savviest investors put his money in a rival’s fund

August 2, 2018August 2, 2018 | Brian Robins

Tech

A dive into the US mortgage market could be a Credible move for this ASX fintech

August 2, 2018August 2, 2018 | Brian Robins

Tech

How should investors value disruptors like Micro-X, Reva, Visioneering and PainChek?

August 1, 2018August 1, 2018 | Brian Robins